BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12630912)

  • 21. Molecular mechanisms of the development of human disease caused by RET mutations.
    Romeo G
    Jpn J Cancer Res; 1997 Jan; 88(1):Inside front cover. PubMed ID: 9045887
    [No Abstract]   [Full Text] [Related]  

  • 22. Up-regulation of ret by reserpine in the adult rat adrenal medulla.
    Powers JF; Brachold JM; Ehsani SA; Tischler AS
    Neuroscience; 2005; 132(3):605-12. PubMed ID: 15837122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The structure of GFRalpha1 domain 3 reveals new insights into GDNF binding and RET activation.
    Leppänen VM; Bespalov MM; Runeberg-Roos P; Puurand U; Merits A; Saarma M; Goldman A
    EMBO J; 2004 Apr; 23(7):1452-62. PubMed ID: 15044950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tyrosine phosphatase Shp-2 mediates intracellular signaling initiated by Ret mutants.
    D'Alessio A; Califano D; Incoronato M; Santelli G; Florio T; Schettini G; Carlomagno MS; Cerchia L; de Franciscis V
    Endocrinology; 2003 Oct; 144(10):4298-305. PubMed ID: 12959980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrinsic susceptibility to misfolding of a hot-spot for Hirschsprung disease mutations in the ectodomain of RET.
    Kjaer S; Ibáñez CF
    Hum Mol Genet; 2003 Sep; 12(17):2133-44. PubMed ID: 12915470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of RET autophosphorylation sites by mass spectrometry.
    Kawamoto Y; Takeda K; Okuno Y; Yamakawa Y; Ito Y; Taguchi R; Kato M; Suzuki H; Takahashi M; Nakashima I
    J Biol Chem; 2004 Apr; 279(14):14213-24. PubMed ID: 14711813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells.
    Maeda K; Murakami H; Yoshida R; Ichihara M; Abe A; Hirai M; Murohara T; Takahashi M
    Biochem Biophys Res Commun; 2004 Oct; 323(1):345-54. PubMed ID: 15351743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neural cells in the esophagus respond to glial cell line-derived neurotrophic factor and neurturin, and are RET-dependent.
    Yan H; Bergner AJ; Enomoto H; Milbrandt J; Newgreen DF; Young HM
    Dev Biol; 2004 Aug; 272(1):118-33. PubMed ID: 15242795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GDNF, Ret, GFRalpha1 and 2 in the adult rat retino-tectal system after optic nerve transection.
    Lindqvist N; Peinado-Ramónn P; Vidal-Sanz M; Hallböök F
    Exp Neurol; 2004 Jun; 187(2):487-99. PubMed ID: 15144875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein.
    Bongarzone I; Vigano E; Alberti L; Mondellini P; Uggeri M; Pasini B; Borrello MG; Pierotti MA
    Oncogene; 1999 Aug; 18(34):4833-8. PubMed ID: 10490816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel type of mutation in the cysteine rich domain of the RET receptor causes ligand independent activation.
    Arlt DH; Baur B; Wagner B; Höppner W
    Oncogene; 2000 Jul; 19(30):3445-8. PubMed ID: 10918602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site.
    Anders J; Kjar S; Ibáñez CF
    J Biol Chem; 2001 Sep; 276(38):35808-17. PubMed ID: 11445581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducible dimerization of RET reveals a specific AKT deregulation in oncogenic signaling.
    Frêche B; Guillaumot P; Charmetant J; Pelletier L; Luquain C; Christiansen D; Billaud M; Manié SN
    J Biol Chem; 2005 Nov; 280(44):36584-91. PubMed ID: 16123037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected structures formed by the kinase RET C634R mutant extracellular domain suggest potential oncogenic mechanisms in MEN2A.
    Liu Y; De Castro Ribeiro O; Haapanen O; Craven GB; Sharma V; Muench SP; Goldman A
    J Biol Chem; 2022 Oct; 298(10):102380. PubMed ID: 35985422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domain.
    Heiz M; Grünberg J; Schubiger PA; Novak-Hofer I
    J Biol Chem; 2004 Jul; 279(30):31149-56. PubMed ID: 15151998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osmotic stress-mediated activation of RET kinases involves intracellular disulfide-bonded dimer formation.
    Takeda K; Kato M; Wu J; Iwashita T; Suzuki H; Takahashi M; Nakashima I
    Antioxid Redox Signal; 2001 Jun; 3(3):473-82. PubMed ID: 11491658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosines outside the kinase core and dimerization are required for the mitogenic activity of RET/ptc2.
    Durick K; Yao VJ; Borrello MG; Bongarzone I; Pierotti MA; Taylor SS
    J Biol Chem; 1995 Oct; 270(42):24642-5. PubMed ID: 7559572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A RING finger motif regulates transforming activity of the rfp/ret fusion gene.
    Hasegawa N; Iwashita T; Asai N; Murakami H; Iwata Y; Isomura T; Goto H; Hayakawa T; Takahashi M
    Biochem Biophys Res Commun; 1996 Aug; 225(2):627-31. PubMed ID: 8753810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and chemical inhibition of the RET tyrosine kinase domain.
    Knowles PP; Murray-Rust J; Kjaer S; Scott RP; Hanrahan S; Santoro M; Ibáñez CF; McDonald NQ
    J Biol Chem; 2006 Nov; 281(44):33577-87. PubMed ID: 16928683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rapid method for the purification of wild-type and V804M mutant ret catalytic domain: A tool to study thyroid cancer.
    Sala E; Mologni L; Cazzaniga S; Papinutto E; Gambacorti-Passerini C
    Int J Biol Macromol; 2006 Aug; 39(1-3):60-5. PubMed ID: 16490247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.